Forge Biologics
Forge Biologics: Transforming gene therapy ideas into life-changing realities, partnering with innovators since 2020.
Founded
2020Forge Biologics: Transforming gene therapy ideas into life-changing realities, partnering with innovators since 2020.
Founded in 2020 and headquartered in Grove City, Ohio, Forge Biologics is a gene therapy development engine dedicated to enabling access to life-changing gene therapies. The company collaborates with scientists, physicians, biotech and pharma companies, and patient groups to transform innovative gene therapy concepts into reality. Forge Biologics offers comprehensive services that span from preclinical development to clinical and commercial manufacturing, focusing on accelerating the development and delivery of gene therapies to patients in need.
Notable figures affiliated with Forge Biologics include experienced leaders in biotechnology and pharmaceuticals, though specific names are not provided. The company has attracted significant investment from prominent venture capital firms, underscoring its potential and industry impact. Key achievements include the successful establishment of a state-of-the-art manufacturing facility and forming strategic partnerships within the gene therapy community. Forge Biologics' overall impact lies in its contribution to advancing gene therapy treatments, offering hope for patients with genetic disorders.
Companies similar to Forge Biologics include Regenxbio, Jaguar Gene Therapy, Exegenesis Bio and Limelight Bio.
Forge Biologics was founded in 2020.
Forge Biologics' headquarters is located in Columbus, OH, US.
Forge Biologics' most recent funding round was for $90M (USD) in September 2022.
As of Sep 12, 2022, Forge Biologics has disclosed funding of $330M (USD). Undisclosed round amounts are excluded.
Forge Biologics has 355 employees as of Feb 5, 2024.
Limelight Bio
limelightbio.com
